WSJ Health Blog: Medical Technology Innovation Shifts To Emerging Markets.
Suddenly the competition is up the street AND around the world. Contact me if you'd like some assistance evaluating the international market and your revenue-at-risk. (healthcarestrategist@gmail.com)
"...med tech innovators are increasingly going outside the U.S. “to seek clinical data, new-product registration and first revenue,” and that U.S. consumers “could eventually be last in line” to benefit from med tech advances. And...developing nations are becoming “the leading markets for smaller, faster, more affordable devices that enable delivery of care anywhere and help bend the healthcare cost curve downward.”Let's see. On a per-episode basis, many international options cost significantly less than U.S. health care. And now the patients heading off-shore gain early access to leading-edge technology. Lower prices, better technology. Yeah, who'd want to swap for THAT?
"They’re able to do so because they aren’t saddled by the “entrenched health-care system infrastructure that seeks to maintain the status quo.” (emphasis mine) Since that entrenched health-care infrastructure isn’t likely to disappear any time soon — nor do we likely want to swap our entire system for that of a developing country — one key step is to “rethink our reimbursement system..."
Suddenly the competition is up the street AND around the world. Contact me if you'd like some assistance evaluating the international market and your revenue-at-risk. (healthcarestrategist@gmail.com)
Comments